This study uses Medicare data to characterize physician ordering of low-value breast cancer services including imaging for staging low-risk disease and IMRT after breast-conservation surgery.
This study examined the use of active surveillance and its predictors in prostate cancer treatment, finding that its use is low and should increase to reduce the overtreatment of screening-detected prostate cancer.
This survey study found low use of decision aids among specialists treating patients with prostate cancer.
Lu-Yao and coauthors determined the long-term survival impact of primary androgen-deprivation therapy in older men with localized (T1/T2) prostate cancer.
Hoffman et al determine the impact of physicians on the management of low-risk prostate cancer with up-front treatment vs observation.
Preston and colleagues determine the association between 5α-reductase inhibitor use and development of high-grade or lethal prostate cancer.
Taylor et al assess the effectiveness of two 2 decision aids in helping men make informed prostate cancer screening decisions. Reuland and Pignone provide an Invited Commentary.
Richman et al examined postdiagnostic fat intake in relation to lethal prostate cancer and all-cause mortality. See also the invited commentary by Freedland.